|
|
|
|
|
Advancing clinical excellence across women’s health
Expertly curated research and insights from JAMA and the JAMA Network
|
|
|
|
In this edition of JAMA+ Women’s Health, an Original Investigation in JAMA Network Open links cardiovascular health during pregnancy, as measured by a modified Life’s Essential 8 score, to incident cardiometabolic disease over 7 years of follow-up; an Original Investigation in JAMA Internal Medicine uses a sibling-matched cohort of more than 700,000 mother-child pairs to evaluate whether prenatal acetaminophen (paracetamol) exposure is associated with autism or ADHD; a Viewpoint in JAMA Internal Medicine considers how discrepancies in breast cancer risk scores affect decisions about supplemental mammographic screening; and a Special Communication in JAMA Health Forum reviews the evidence on how state-level abortion bans are reshaping the OBGYN workforce. This week’s audio episode covers mail-order pharmacy dispensing of mifepristone for abortion after in-person screening.
Explore the latest curated research, commentary, and multimedia from JAMA+ Women’s Health in the featured articles below.
Editor’s Picks in this week’s JAMA+ Women’s Health:
This Medical News feature reports on new evidence that acetaminophen use during pregnancy is unlikely to cause autism or ADHD, contextualizing the sibling-matched findings alongside negative-control analyses that argue prior positive signals likely reflect familial confounding rather than a true drug effect. (JAMA)
|
|
Original Investigation
JAMA Network Open
Life’s Essential 8 in Pregnancy and Time to Incident Cardiometabolic Disease Over 7 Years Follow-Up
Ellen C. Francis; Shalin Patel; Anushka Pande; et al
JAMA Internal Medicine
Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts
Shan Luo; Qiaowa Gong; Yujie Ai; Eric Yuk Fai Wan; et al
Viewpoint
JAMA Internal Medicine
When Risk Scores Meet Mammography—Navigating Supplemental Screening Decisions
Gianna M. Aliberti, MD, MPH; Amy R. Weinstein, MD, MPH; Mara A. Schonberg, MD, MPH
Special Communication
JAMA Health Forum
State-Level Abortion Bans and the OBGYN Workforce: A Review of Current Evidence
Julia Strasser, DrPH; Kavita Arora, MD, MBE, MS; Anitra Beasley, MD, MPH; Kari White, PhD, MPH; et al
FROM JAMA THIS WEEK
Acetaminophen Use During Pregnancy Is Unlikely to Cause Autism or ADHD, New Study Reaffirms
Samantha Anderer
Audio
Mail-Order Pharmacy Dispensing of Mifepristone for Abortion After In-Person Screening
|
|
| |
|
Linda Brubaker, MD, MS
JAMA+ Women’s Health Editor in Chief
|
 |
|
|
JAMA+ Women's Health features expertly curated research and insights published across the JAMA Network. Please submit your manuscripts directly to JAMA and the JAMA Network journals. More information and complete instructions are available at the For Authors page.
|
|
|
|
|
|
Thank you for subscribing to JAMA Network email alerts. This message was sent to ai.nt@pctu.edu.vn by updates@email.jamanetwork.com.
To update your contact information, change your email preferences, or unsubscribe, click here.
To ensure you always receive JAMA Network emails, add the email address updates@email.jamanetwork.com to your address book.
To unsubscribe by mail, contact:
JAMA Network
AMA Plaza
330 N Wabash Ave
Chicago, IL 60611
Or call (800) 621-8335.
|
      |
|
©2026 American Medical Association. All rights reserved.
|
|
|
